Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cv Sciences Inc (OP:CVSI)

0.0298 +0.0001 (+0.34%)
Streaming Delayed Price Updated: 9:36 AM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cv Sciences Inc

News headline image
CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results
Via ACCESS Newswire
News headline image
CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results
Via ACCESS Newswire
News headline image
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026
Via ACCESS Newswire
News headline image
CV Sciences Unveils New Aura Collection THC Fizz Tablets
Via ACCESS Newswire
News headline image
CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth
Via ACCESS Newswire
News headline image
CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Reports Third Quarter 2025 Financial Results
Via ACCESS Newswire
News headline image
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025
Via ACCESS Newswire
News headline image
CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Reports Second Quarter 2025 Financial Results
Via ACCESS Newswire
News headline image
CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Reports First Quarter 2025 Financial Results
Via ACCESS Newswire
News headline image
CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results
Via ACCESS Newswire
News headline image
CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods
Via ACCESS Newswire
News headline image
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025
Via ACCESS Newswire
Pharmaceutical & Hemp Wellness Segments Of Cannabidiol Market Could See the Fastest Growth Rates Through 2028
Palm Beach, FL – November 15, 2021 – FinancialNewsMedia.com News Commentary – Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects.... 
Via FinancialNewsMedia
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.